We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBTG:NYSEGlobal Business Travel Group, Inc. Analysis

Data as of 2026-05-19 - not real-time

$9.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Global Business Travel Group delivered a Q4 FY2025 revenue of $792 million, a 34% YoY increase, and GAAP EPS of $0.17, comfortably beating consensus estimates, while the current market price of $9.44 sits well below the DCF‑derived fair value of roughly $20.9, suggesting significant upside. Revenue growth remains robust at 35% YoY, and forward EPS guidance points to accelerating profitability, reinforcing the growth narrative despite a modest trailing profit margin of ~3%. Technical indicators show the stock trading above its 20‑day and 50‑day SMAs, with a bullish MACD crossover, but an RSI of 84 signals short‑term overbought conditions and a decreasing volume trend adds caution.
The recent announcement of a multibillion‑dollar cash buyout of its software subsidiary and a 57% price rally underscore strong market enthusiasm, yet the downgrade from BTIG to neutral and the sector’s inherent cyclicality temper expectations. High 30‑day volatility (>130%) and a beta above 1 highlight elevated price swings, while the company’s global footprint spreads geographic exposure. Overall, the fundamentals and valuation gap favor a buy stance, but short‑term positioning should account for the overbought technical backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating overbought conditions
  • Decreasing volume trend
  • Recent earnings beat but heightened short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and forward EPS acceleration
  • Strategic acquisition of software subsidiary
  • DCF valuation showing substantial upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term undervaluation relative to intrinsic value
  • Exposure to recovery in corporate travel demand
  • Diversified global operations reducing single‑market risk

Key Metrics & Analysis

Financial Health

Revenue Growth35.30%
Profit Margin2.93%
P/E Ratio59.0
ROE6.45%
ROA3.16%
Debt/Equity98.80
P/B Ratio3.1
Op. Cash Flow$165.0M
Free Cash Flow$340.8M

Technical Analysis

TrendNeutral
RSI84.3
Support$5.61
Resistance$9.54
MA 20$7.81
MA 50$6.48
MA 200$7.19
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$20.87
Target Price$9.50
Upside/Downside0.64%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.13
Volatility134.65%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.